USA Vaccine Adjuvants Market Size, Share & Industry Trends Analysis Report By Type (Particulate, Adjuvant Emulsion, Pathogen, Combination, and Others), By Administration, By Application, Outlook and Forecast, 2023 - 2030

TABLE 1 US Vaccine Adjuvants Market, 2019 - 2022, USD Million
TABLE 2 US Vaccine Adjuvants Market, 2023 - 2030, USD Million
TABLE 3 Partnerships, Collaborations and Agreements– Vaccine Adjuvants Market
TABLE 4 Product Launches And Product Expansions– Vaccine Adjuvants Market
TABLE 5 Acquisition and Mergers– Vaccine Adjuvants Market
TABLE 6 Trials and Approvals- Vaccine Adjuvants Market
TABLE 7 US Vaccine Adjuvants Market, by Type, 2019 - 2022, USD Million
TABLE 8 US Vaccine Adjuvants Market, by Type, 2023 - 2030, USD Million
TABLE 9 US Vaccine Adjuvants Market, by Administration, 2019 - 2022, USD Million
TABLE 10 US Vaccine Adjuvants Market, by Administration, 2023 - 2030, USD Million
TABLE 11 US Vaccine Adjuvants Market, by Application, 2019 - 2022, USD Million
TABLE 12 US Vaccine Adjuvants Market, by Application, 2023 - 2030, USD Million
TABLE 13 Key Information – Novavax, Inc.
TABLE 14 Key Information – SPI Pharma, Inc.
TABLE 15 Key Information – Agenus Inc.
TABLE 16 Key Information – InvivoGen SAS
TABLE 17 Key Information – Seppic S.A.
TABLE 18 Key Information – CSL Limited
TABLE 19 Key Information – Croda International PLC
TABLE 20 Key Information - Merck & Co., Inc.

List of Figures
FIG 1 Methodology for the research
FIG 2 US Vaccine Adjuvants Market, 2019 - 2030, USD Million
FIG 3 Key Factors Impacting the Vaccine Adjuvants Market
FIG 4 KBV Cardinal Matrix
FIG 5 Key Leading Strategies: Percentage Distribution (2019-2023)
FIG 6 Key Strategic Move: (Product Launches and Product Expansions : 2017, Jun – 2021, Jun) Leading Players
FIG 7 Porter’s Five Forces Analysis – Vaccine Adjuvants Market
FIG 8 US Vaccine Adjuvants Market Share, by Type, 2022
FIG 9 US Vaccine Adjuvants Market Share, by Type, 2030
FIG 10 US Vaccine Adjuvants Market, by Type, 2019 - 2030, USD Million
FIG 11 US Vaccine Adjuvants Market Share, by Administration, 2022
FIG 12 US Vaccine Adjuvants Market Share, by Administration, 2030
FIG 13 US Vaccine Adjuvants Market, by Administration, 2019 - 2030, USD Million
FIG 14 US Vaccine Adjuvants Market Share, by Application, 2022
FIG 15 US Vaccine Adjuvants Market Share, by Application, 2030
FIG 16 US Vaccine Adjuvants Market, by Application, 2019 - 2030, USD Million
FIG 17 SWOT Analysis: Novavax, Inc.
FIG 18 SWOT Analysis: Agenus Inc.
FIG 19 SWOT Analysis: InvivoGen SAS
FIG 20 SWOT Analysis: Seppic S.A.
FIG 21 SWOT Analysis: CSL Limited
FIG 22 SWOT Analysis: Merck & Co., Inc.